Top rated alzheimer's disease clinical trials in Boston, Massachusetts
Here are the top 10 medical studies for alzheimer's disease in Boston, Massachusetts
Popular filter options for alzheimer's-disease boston trials
Phase 3 Clinical Trials
View 61 phase 3 medical studies.
Glucagon-like peptide-1 (GLP-1) receptor agonist
Semaglutide for Early Alzheimer's Disease
Recruiting1 awardPhase 3
Methuen, Massachusetts
This trial is to test whether the medication semaglutide has a positive effect on early Alzheimer's disease. The study will last for up to 173 weeks, and participants will have 17 clinic visits and 1 phone call with the study doctor. The study includes various tests and scans, and at 10 of the clinic visits participants will have blood samples taken. The trial is only for women.
Glucagon-like peptide-1 (GLP-1) receptor agonist
Semaglutide for Early Alzheimer's Disease
Recruiting1 awardPhase 3
Methuen, Massachusetts
This trial is testing whether semaglutide has a positive effect on early Alzheimer's disease by comparing it to a placebo. There will be 17 clinic visits and 1 phone call with the study doctor, and various tests and scans will be performed. The study will last for up to 173 weeks.
Small Molecule
ALZ-801 for Alzheimer's Disease
Recruiting1 awardPhase 3
Plymouth, Massachusetts
This trial is testing a potential Alzheimer's treatment in people with a specific gene type. It is double-blind, meaning neither the participants nor the researchers know who is receiving the treatment or the placebo.
Clinical Trials With No Placebo
View 61 medical studies that do not have a placebo group.
Procedure
ECT for Dementia
Recruiting1 award8 criteria
Belmont, Massachusetts
This trial will compare two treatments for severe agitation in patients with dementia: electroconvulsive therapy plus usual care (ECT+UC) versus placebo simulated electroconvulsive therapy plus usual care (S-ECT+UC). The study will also compare the safety and tolerability of the two treatments.
View More Alzheimer's-disease Boston Trials
See another 41 medical studies focused on alzheimer's-disease boston.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā in general, verified trials respond to patients within a few days.